BriaCell Therapeutics Corp. (BCTX) Financials
BCTX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2024-01-31 | 12.2 million | 20.5 million |
| 2023-10-31 | 18.6 million | 16.1 million |
| 2023-07-31 | 27.2 million | 30.9 million |
| 2023-04-30 | 29.7 million | 35.6 million |
BCTX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2024-01-31 | -7.4 million | 500155 |
| 2023-10-31 | -7.6 million | 533816 |
| 2023-07-31 | -10.9 million | 533816 |
| 2023-04-30 | -5.3 million | 281189 |
BCTX Net Income
No data available :(
BCTX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2024-01-31 | 6.2 million | - | - |
| 2023-10-31 | 13.6 million | - | - |
| 2023-07-31 | 21.3 million | - | - |
| 2023-04-30 | 28.2 million | - | - |
BCTX Shares Outstanding
BCTX Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2024-01-31 | - | 8.3 million | 1.6 million | - |
| 2023-10-31 | - | 6.9 million | 1.6 million | - |
| 2023-07-31 | - | 5.2 million | 2.5 million | - |
| 2023-04-30 | - | 3.9 million | 1.8 million | - |
BCTX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2024-01-31 | - | - |
| 2023-10-31 | - | 3735 |
| 2023-07-31 | - | 3861 |
| 2023-04-30 | - | 3816 |
BCTX
Price: $2.11
52 week price:
Earnings Per Share: -0.79 USD
P/E Ratio: -2.27
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 135600
Market Capitalization: 44.6 million